Francisco Oliveira - Net Worth and Insider Trading

Francisco Oliveira Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Francisco Oliveira owns 1 companies in total, including Ikena Oncology Inc (IKNA) .

Click here to see the complete history of Francisco Oliveira’s form 4 insider trades.

Insider Ownership Summary of Francisco Oliveira

Ticker Comapny Transaction Date Type of Owner
IKNA Ikena Oncology Inc 2022-02-18 Principal Accounting Officer

Francisco Oliveira Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Francisco Oliveira Ownership Network

Ownership Network List of Francisco Oliveira

No Data

Ownership Network Relation of Francisco Oliveira

Insider Network Chart

Francisco Oliveira Owned Company Details

What does Ikena Oncology Inc do?

Who are the key executives at Ikena Oncology Inc?

Francisco Oliveira is the Principal Accounting Officer of Ikena Oncology Inc. Other key executives at Ikena Oncology Inc include CFO & Head of Corp. Dev. Jotin Marango , Chief Scientific Officer Xiaoyan Michelle Zhang , and 10 percent owner Atlas Venture Fund Xi, L.p. .

Ikena Oncology Inc (IKNA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ikena Oncology Inc (IKNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ikena Oncology Inc (IKNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ikena Oncology Inc (IKNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ikena Oncology Inc Insider Transactions

No Available Data

Francisco Oliveira Mailing Address

Above is the net worth, insider trading, and ownership report for Francisco Oliveira. You might contact Francisco Oliveira via mailing address: Ikena Oncology, Inc., 645 Summer Street, Suite 101, Boston Ma 02210.

Discussions on Francisco Oliveira

No discussions yet.